As Competitors Pursue Alternatives Medgenics’ INFRADURE Gains Prominence for its Potential to Treat Hepatitis

[ACN Newswire] – Medgenics’ (NYSEAMEX: MDGN) INFRADURE(TM) provides sustained production and delivery of interferon-alpha for the treatment of hepatitis. INFRADURE(TM) is a kind of miniature pump that is impacted into … more

View todays social media effects on VRTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Vertex is hiring next, click here to view